Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cells: the next therapeutic frontier.

H David Humes1

  • 1Department of Internal Medicine, University of Michigan Medical School, 4520 MSRB I, Box 0651, 1150 W. Medical Center Drive, Ann Arbor, MI 48109-0726, USA. dhumes@umich.edu

Transactions of the American Clinical and Climatological Association
|March 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunomodulatory Effects of a Cell Processing Device: Insights from Single Cell RNA Sequencing and Gene Set Enrichment Analysis.

bioRxiv : the preprint server for biology·2025
Same author

Use of the Selective Cytopheretic Device with Continuous Renal Replacement Therapy in Children: A Comparison of Contemporary Cohorts.

Blood purification·2025
Same author

Selective Cytopheretic Device Therapy in the Context of Extracorporeal Membrane Oxygenation.

Medicina (Kaunas, Lithuania)·2025
Same author

Regional Citrate Anticoagulation and Infectious Complications in Critically Ill Children and Young Adults Receiving Continuous Renal Replacement Therapy.

Nephron·2025
Same author

Management dilemma in choosing evolving treatments in neutropenic septic shock.

Pediatric nephrology (Berlin, Germany)·2025
Same author

The Impact of the Selective Cytopheretic Device on Neutrophil-to-Lymphocyte Ratios and Hematological Parameters in Acute Kidney Injury: A Pooled Analysis.

Nephron·2025

Cell therapy, using human stem/progenitor cells, offers a dynamic approach for complex diseases like renal failure. This regenerative medicine strategy complements existing treatments, showing great potential for clinical success.

Area of Science:

  • Translational medicine
  • Regenerative medicine
  • Cellular and molecular biology

Background:

  • Cell-based therapy is a rapidly advancing field with potential applications in various clinical disorders.
  • While protein-based therapeutics have limitations in complex diseases, cell therapy offers a dynamic and individualized approach.
  • Successful examples include blood transfusions and bone marrow transplantation, with new applications emerging.

Purpose of the Study:

  • To review the application of human stem/progenitor cells in treating acute and chronic renal failure.
  • To explore cell-based therapy as an extension of current renal replacement therapies like hemodialysis and hemofiltration.

Main Methods:

  • Focus on the use of human stem/progenitor cells.
  • Review of existing literature and clinical research in cell-based renal therapy.

Related Experiment Videos

Main Results:

  • Cell therapy presents innovative methods for drug delivery, immunotherapy, and tissue regeneration.
  • Human stem/progenitor cells show promise in treating renal failure, potentially improving upon current substitution processes.

Conclusions:

  • Cell-based therapy holds significant potential for treating complex diseases, including renal failure.
  • Technological advancements are crucial for translating cell therapy into widespread medical practice.
  • The field is poised for success, with many cell-based therapies under clinical evaluation.